Jnba Financial Advisors Haleon PLC Transaction History

Jnba Financial Advisors

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 07, 2024	SELL	$7.78 - $8.62 $4,668 - $5,171	-600 Reduced 83.1%	122 $1,000
Q2 2023 Aug 03, 2023	SELL	$8.04 - $9.0 $1,607 - $1,800	-200 Reduced 21.69%	722 $6,000
Q1 2023 May 01, 2023	SELL	$7.57 - $8.37 $2,399 - $2,653	-317 Reduced 25.59%	922 $7,000
Q3 2022 Nov 07, 2022	BUY	$5.63 - $7.5 $6,975 - $9,292	1,239 New	1,239 $8,000

639

412M

149K

16K

Ticker HLN
Exchange
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 4,617,290,240
Market Cap $44.8B
Description
Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...

Get notified when there are updates to the investment portfolio of Jnba Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Jnba Financial Advisors with notifications on news.